Disease Clinical Trial - Quantification of Microbiota in Health & Diseases

Status Recruiting

Clinical Trial Summary

Microbiota consists of trillions of microorganisms located in all the biological cavity. The relationships between individual health status and microbiota are based on a sort of "mutual cooperation." The balance of the microbiota can be compromised by various factors such as environmental, psycho-physical stress, malnutrition (over or low), breastfeeding, chronic diseases, oncology and pharmacological treatments (especially antibiotics and chemotherapics). The impact of dysbiosis on today's society affects over 70% of the world population

Clinical Trial Description

Intestinal microbiota is defined as the strongest modulator of the human genome and it is considered the "second brain" of our organism for its bi-directional communication with the central nervous system. Microbiota consists of trillions of microorganisms located in all the biological cavity, In the intestine it is distributed in ecological niches having multiple metabolic activities which influence individual health. Microbiota acts as barrier against pathogens, regulating the absorption of nutrients, the production of energy and the development of the immune system4. Intestinal bacteria are generally divided into 4 Phylum: Firmicutes, Actinobacteria, Proteobacteria and Bacteriodetes, in which their proportion shows a correlation with individuals health status. When in equilibrium among them, these bacteria are essential for the good health of the digestive tract, the good function of immune system and for brain performace. The relationships between individual health status and microbiota are based on a sort of "mutual cooperation." The balance of the microbiota can be compromised by various factors such as environmental, psycho-physical stress, malnutrition (over or low), breastfeeding, chronic diseases, oncology and pharmacological treatments (especially antibiotics and chemotherapics). This disequilibrium leads to altered capability of bacteria to properly extract calories from food affecting the trend of many pathophisilogical status such as obesity, allergic states, inflammatory bowel syndromes cardiovascular diseases, metabolic, oncological and neurodegenerative diseases. The impact of dysbiosis on today's society affects over 70% of the world population ;

Study Design

Related Conditions & MeSH terms

Disease

Clinical Trial Details

NCT number	NCT03388424
Study type	Observational
Source	University of Catanzaro
Contact	Luca Gallelli, MD
Phone	+390961712322
Email	gallelli@unicz.it
Status	Recruiting
Phase
Start date	November 22, 2017
Completion date	November 21, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00767702` - Use of Population Descriptors in Human Genetic Research
Recruiting	`NCT05608096` - European Registry for Hemadsorption in Sepsis With the Seraph Filter
Completed	`NCT02868177` - Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes	Phase 2/Phase 3
Completed	`NCT05564559` - Multifamily Group Psychoeducation for SUD's in Turkey	N/A
Enrolling by invitation	`NCT03337893` - Investigation of Breastfeeding Protection Against Infant Infections and Childhood Diseases	N/A
Completed	`NCT03722459` - Novel MRI Sequence- MR Fingerprinting	N/A
Not yet recruiting	`NCT06271538` - Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome	Phase 4
Completed	`NCT03295123` - Outcome of Children Born After Pregnancy Denial
Terminated	`NCT04639310` - XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy	Phase 3
Not yet recruiting	`NCT05853991` - Effects of Touch on Brain Connectivity and Metabolic Biomarkers in Preterm Infants	N/A
Active, not recruiting	`NCT02195778` - Assessment of Health Literacy Among Adult Patients in the United Arab Emirates to Facilitate Clinical Trials Recruitment.	N/A
Recruiting	`NCT06081452` - Public Survey on Breath Testing for Health and Disease
Recruiting	`NCT04973774` - A Multi-center Prospective Study of Branch Atheromatous Disease in China
Not yet recruiting	`NCT04866732` - Physical Activity Program for Cardiac Health Among Older African American Populations	N/A
Completed	`NCT01043133` - Study of Medical Student Use of Templates to Document Outpatient Asthma Care in Electronic Medical Record	N/A
Recruiting	`NCT01317979` - Asian Diabetes Surgery Study (ADSS): Clinical Predictor for the Success of Metabolic Surgery	N/A
Recruiting	`NCT06036433` - Light Therapy Plus Exercise to Improve Motor, Non-Motor Symptoms and QoL in Parkinson's Disease	N/A
Completed	`NCT05214534` - Contribution of SuPAR for Patients in a Situation of Uncertainty Downstream of Emergencies
Completed	`NCT05930626` - Biomarkers of Acrylamide, Glycidol, POPs, PFAS and Disease Outcomes and OMICs Signatures
Completed	`NCT04210713` - Neuroimmune Dysfunction in Alcohol Use Disorder	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Quantification of Microbiota in Health and Diseases — qMHD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms